T1D Risk Assessment in Kids With Relatives
NCT02184676 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 512
Last updated 2025-12-11
Summary
The purpose of this study is to determine whether early immunological markers (activation of autoreactive T lymphocytes) precede and are predictive of the appearance of autoantibodies in children born from type 1 diabetic parents.
Conditions
Interventions
- BIOLOGICAL
-
Analysis of early immune modifications
* blood and stool sampling in parents during pregnancy (at enrollment, i.e. 7th-8th month of pregnancy) * cord blood sampling * stool sampling in mothers and newborns at birth (day 7) * blood and stool sampling in children at the age of 8, 18, 30 and 42 months
- OTHER
-
Collection of clinical and socio-demographic data
1. Questionnaire filled in by clinicians at enrollment and at birth 2. Self-administered questionnaire filled by parents at enrollment, at birth, and then at month 8, 18, 30 and 42
Sponsors & Collaborators
-
Institut National de la Santé et de la Recherche Médicale (INSERM) U1016 - Institut Cochin, Immunology of Diabetes Team, Paris, France
collaborator UNKNOWN -
INSERM U1153, Epidemiology Research Unit on Perinatal Health and Women and Children Health, Port-Royal Hospital, Paris, France
collaborator UNKNOWN -
Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement
collaborator OTHER -
Commissariat A L'energie Atomique
collaborator OTHER_GOV -
URC-CIC Paris Descartes Necker Cochin
collaborator OTHER -
Assistance Publique - Hôpitaux de Paris
lead OTHER
Principal Investigators
-
Roberto Mallone, M.D, Ph.D. · INSERM U1016
Study Design
- Allocation
- NA
- Purpose
- SCREENING
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 1 Day
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-05-28
- Primary Completion
- 2019-05-17
- Completion
- 2019-05-17
Countries
- France
Study Locations
More Related Trials
-
Prevention of Clinical Onset of Type 1 Diabetes in High Risk First Degree Relatives
NCT00654121 ·Status: COMPLETED ·Phase: PHASE2
-
Pre-POINT-Early Study
NCT02547519 ·Status: COMPLETED ·Phase: PHASE2
-
Nutritional Prevention Pilot Trial for Type 1 Diabetes
NCT00570102 ·Status: COMPLETED ·Phase: PHASE2
-
Rituximab in New Onset Type 1 Diabetes
NCT00279305 ·Status: COMPLETED ·Phase: PHASE2
-
EXtremely Early-onset Type 1 Diabetes EXtremely Early-onset Type 1 Diabetes (A Musketeers' Memorandum Study)
NCT03369821 ·Status: RECRUITING
-
The Diabetes Prevention Trial of Type 1 Diabetes (DPT-1)
NCT00004984 ·Status: COMPLETED ·Phase: PHASE3
-
T1DM Immunotherapy Using CD4+CD127lo/-CD25+ Polyclonal Tregs
NCT01210664 ·Status: COMPLETED ·Phase: PHASE1
-
Type 1 Diabetes, Immunology, Genetics & Endogenous Insulin Production
NCT03490773 ·Status: COMPLETED
-
Oral Insulin for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes Mellitus
NCT00419562 ·Status: COMPLETED ·Phase: PHASE3
-
Immunotherapy of the Recent-onset Type 1 Diabetes in Adolescents With Repeated Courses of Rituximab
NCT07041268 ·Status: RECRUITING ·Phase: PHASE2
-
Safety and Efficacy Study of Autologous Stem Cell Transplantation for Early Onset Type I Diabetes Mellitus
NCT00315133 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Continuous Glucose Monitoring in Adolescents With Poorly Controlled Type 1 Diabetes
NCT01586065 ·Status: COMPLETED ·Phase: NA
-
UK Islet Autoantibody Registry
NCT07125365 ·Status: RECRUITING
-
T1D Pregnancy & Me
NCT06959316 ·Status: RECRUITING
-
Analysis of Viral Infections' Exposition Preceding the Type 1 Diabetes (T1D) Diagnostic in Children of the Isis-Diab Cohort. Search for Explanations of of the Disease's Early Onset
NCT02425410 ·Status: UNKNOWN
-
Determinants of Glycaemic Control in Children With Type 1 Diabetes
NCT06325111 ·Status: RECRUITING
-
Collection of Information-Rich Type 1 Diabetes Data
NCT01223560 ·Status: COMPLETED ·Phase: NA
-
Prematurity Prevalence Among T1D Patients and Its Characteristics Compared With Premature-born Non-diabetic Patients
NCT02929953 ·Status: COMPLETED
-
Starting Technology in At Risk Type 1 Diabetes Study
NCT06453928 ·Status: RECRUITING ·Phase: NA
-
Immunotherapy with Autologous Tregs in T1DM
NCT06708780 ·Status: RECRUITING ·Phase: PHASE1
-
Fr1da Insulin Intervention
NCT02620072 ·Status: COMPLETED ·Phase: PHASE2
-
Intranasal Insulin for Prevention of Type 1 Diabetes
NCT00223613 ·Status: UNKNOWN ·Phase: PHASE3
-
A Study of LY2605541 and Glargine in Participants With Type 1 Diabetes
NCT01769404 ·Status: COMPLETED ·Phase: PHASE1
-
T1DM Immunotherapy Using Polyclonal Tregs + IL-2
NCT02772679 ·Status: COMPLETED ·Phase: PHASE1
-
Reversing Type 1 Diabetes After it is Established
NCT01106157 ·Status: COMPLETED ·Phase: PHASE1/PHASE2